Results 231 to 240 of about 31,883 (289)

Biobank participants' perspectives on receiving genetic risk information from a biobank - the case of haemochromatosis. [PDF]

open access: yesBMC Med Genomics
Clancy J   +6 more
europepmc   +1 more source

Genetic, lifestyle and environmental influences on health: a Finnish biobank recall study protocol (BioRecall). [PDF]

open access: yesBMJ Open
Sillanpää E   +11 more
europepmc   +1 more source

Spatial transcriptomics in epilepsy research: Early successes, opportunities, and challenges

open access: yes
Epilepsia, EarlyView.
Donald J. Phillips   +4 more
wiley   +1 more source

A multilevel perspective on MSH6‐associated Lynch syndrome: Integrating molecular, biological, and clinical insights

open access: yesInternational Journal of Cancer, EarlyView.
Abstract Lynch syndrome (LS) is the most common hereditary colorectal cancer syndrome, caused by a germline pathogenic variant in one of the mismatch repair (MMR) genes. Among these, MSH6‐associated LS represents a distinct subtype with unique molecular and clinical characteristics.
Salwa Ben Yahia   +4 more
wiley   +1 more source

Estimating the use of biological samples in Finnish biobanks and hospital collections. [PDF]

open access: yesEur J Hum Genet
Tupasela A   +19 more
europepmc   +1 more source

ULK4 and CDKN2A polymorphisms influence the risk of developing monoclonal gammopathy of undetermined significance

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Monoclonal gammopathy of undetermined significance (MGUS) is an asymptomatic precursor to multiple myeloma, sharing substantial genetic features with overt malignancy. Given evidence implicating autophagy in myeloma risk, this study examined whether genetic variations in autophagy‐related genes influence MGUS susceptibility.
José Manuel Sánchez‐Maldonado   +54 more
wiley   +1 more source

Home - About - Disclaimer - Privacy